HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,658,160 | +3.6% | 52,000 | -1.5% | 0.02% | +6.7% |
| Q2 2023 | $4,495,392 | +19.9% | 52,800 | +16.6% | 0.02% | +15.4% |
| Q1 2023 | $3,748,575 | +1078.8% | 45,300 | +906.7% | 0.01% | +1200.0% |
| Q3 2021 | $318,000 | -69.9% | 4,500 | -52.6% | 0.00% | -66.7% |
| Q1 2021 | $1,055,000 | -6.5% | 9,500 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,128,000 | +36.1% | 9,500 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $829,000 | -57.1% | 9,500 | -56.0% | 0.00% | -25.0% |
| Q2 2020 | $1,934,000 | -10.1% | 21,600 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $2,152,000 | +126.3% | 21,600 | +1.9% | 0.01% | +25.0% |
| Q3 2017 | $951,000 | +225.7% | 21,200 | +194.4% | 0.00% | +300.0% |
| Q1 2017 | $292,000 | -53.8% | 7,200 | -67.0% | 0.00% | -66.7% |
| Q2 2016 | $632,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |